Search / Trial NCT00000478

Asymptomatic Cardiac Ischemia Pilot (ACIP) Study

Launched by NATIONAL HEART, LUNG, AND BLOOD INSTITUTE (NHLBI) · Oct 27, 1999

Trial Information

Current as of December 09, 2024

Completed

Keywords

ClinConnect Summary

BACKGROUND:

Asymptomatic cardiac ischemia, frequently designated as silent myocardial ischemia, refers to episodes of objectively demonstrable transient ischemia in the absence of symptoms. Annually, more than one million patients suffer acute myocardial infarction. Of the approximately 700,000 who are discharged alive from the hospital, as many as 180,000 will be asymptomatic but have evidence of myocardial ischemia on a pre-discharge exercise test. Asymptomatic ischemia has been linked with sudden death or myocardial infarction. It is estimated that in the United States over six million ...

Gender

ALL

Eligibility criteria

  • Men aand women with angiographically documented coronary artery disease, ischemia on both stress (exercise) testing and 48-hour ambulatory electrocardiogram monitoring, and who were amenable to revascularization.

Trial Officials

Jerome Cohen

St. Louis University

Richard Davies

University of Ottawa

John Deanfield

St. Bartholomew's Hospital, University of London

Mark Ketterer

Henry Ford Hospital

Genell Knatterud

Hiltrud Mueller

Montefiore Medical Center

Pamela Ouyang

Johns Hopkins University

Carl Pepine

University of Florida

Craig Pratt

Baylor College of Medicine

William Rogers

University of Alabama at Birmingham

Andrew Selwyn

Brigham and Women's Hospital

About National Heart, Lung, And Blood Institute (Nhlbi)

The National Heart, Lung, and Blood Institute (NHLBI) is a leading component of the National Institutes of Health (NIH), dedicated to advancing research and clinical trials focused on cardiovascular, pulmonary, and hematologic diseases. With a mission to improve public health through innovative research, the NHLBI supports a wide range of studies aimed at understanding, preventing, and treating heart and lung conditions. By collaborating with academic institutions, healthcare providers, and patient communities, the NHLBI strives to translate scientific discoveries into effective clinical practices, ultimately enhancing the quality of life for individuals affected by these critical health issues.

Locations

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials